Transplantation of Macroencapsulated Insulin-Producing Cells.

Curr Diab Rep

Joslin Diabetes Center, 1 Joslin Pl, Boston, MA, 02215, USA.

Published: June 2018

Purpose Of Review: There is considerable interest in using macroencapsulation devices as a delivery strategy for transplanting insulin-producing cells. This review aims to summarize recent advances, to highlight remaining challenges, and to provide recommendations for the field.

Recent Findings: A variety of new device designs have been reported to improve biocompatibility and to provide protection for islet/beta cells from immune destruction while allowing continuous secretion of insulin. Some of these new approaches are in clinical trials, but more research is needed to determine how sufficient beta-cell mass can be transplanted in a clinically applicable device size, and that insulin is secreted with kinetics that will safely provide adequate controls of glucose levels. Macroencapsulation is a potential solution to transplant beta cells without immunosuppression in diabetes patients, but new strategies must be developed to show that this approach is feasible.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-018-1028-yDOI Listing

Publication Analysis

Top Keywords

insulin-producing cells
8
transplantation macroencapsulated
4
macroencapsulated insulin-producing
4
cells
4
cells purpose
4
purpose review
4
review considerable
4
considerable interest
4
interest macroencapsulation
4
macroencapsulation devices
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!